Notice of Proposed Sale · 144
NANO-X IMAGING LTD
NNOXNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Nano-X Imaging Ltd.
- Issuer CIK
- 0001795251
- SEC file number
- 001-39461
- Phone
- 972-37359202
- Person for whose account securities are to be sold
- Daniel Ran
- Relationships to issuer
- Officer
- Street
- OFER TECH PARK
- Street (continued)
- 94 SHLOMO SHMELTZER ROAD
- City
- PETACH TIKVA
- State / country code
- L3
- Postal code
- 4970602
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Ordinary Shares | 5,950 | 5,831.00 | 69,590,228 | 08/03/2026 | Nasdaq | Oppenheimer & Co. Inc. |
Broker / market maker — proposed row 1, entry 1
- Name
- Oppenheimer & Co. Inc.
- Street
- 85 Broad St.
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | 11/22/2024 | Shares issued upon vesting of RSUs | Nano-X Imaging Ltd. | 20,000 | N | 11/22/2024 | No consideration, shares issued upon vesting of RSUs |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Notice signature
- Notice date
- 08/03/2026
- Signed
- Ran Daniel By: /s/ Meirav Shemesh Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)
Company context
Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. Nanox combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care.